Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Glioblastoma × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Tracheal Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Lung Neoplasms 1 Laryngeal Diseases 1 Head and Neck Neoplasms 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Adenoid Cystic 1 Breast Neoplasms 1

Interventions

Temozolomide 60 Radiotherapy 25 Bevacizumab 22 Carboplatin 12 Radiation 11 pembrolizumab 10 Irinotecan 7 Surgical Procedures, Operative 6 Carmustine 6 Radiosurgery 5 Nivolumab 5 Everolimus 5 Erlotinib Hydrochloride 5 temsirolimus 4 atezolizumab 4 Vorinostat 4 Lomustine 4 Aminolevulinic Acid 4 tipifarnib 3 Sirolimus 3 Radiotherapy, Intensity-Modulated 3 Paclitaxel 3 Magnetic Resonance Spectroscopy 3 IL13-PE38 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gemcitabine 3 Drug Therapy 3 Cetuximab 3 selinexor 2 poly ICLC 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04772846 2021-02-26

Chloroquine for Glioblastoma.

Egyptian Medical Syndicate

Phase 1/2 Unknown

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡